Alexander disease: Alzheimer disease of the developing brain?

被引:9
|
作者
Castellani, RJ
Perry, G
Brenner, DS
Smith, MA
机构
[1] Univ Maryland, Dept Pathol, Div Neuropathol, Baltimore, MD 21201 USA
[2] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
关键词
Alexander disease; Alzheimer disease; Rosenthal fibers; oxidative injury;
D O I
10.1097/00002093-199910000-00010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alexander disease is a leukodystrophy-like neurodegenerative disease that typically presents in infancy or childhood. The disease is essentially a sporadic condition, and there is no known genetic predisposition or metabolic abnormality. The hallmark of the disease is the diffuse accumulation of Rosenthal fibers (RF) throughout the central nervous system. Although an etiological relationship of the RF to disease pathogenesis has been suspected since the initial description of Alexander disease, such a relationship has not been confirmed. We previously identified a number of oxidative posttranslational modifications, including advanced glycation end products and lipid peroxidation adducts, in intimate association with the RF of Alexander disease. Such oxidative protein damage provides a mechanism, through protein crosslinking, for insolubility and accumulation of RE Notably, these findings show a striking parallel with the biochemical features of age-related neurodegenerative diseases such as Alzheimer disease. Therefore, Alexander disease and Alzheimer disease likely share a common pathogenesis, namely oxidative injury as a potential primary process in the etiology and pathogenesis.
引用
收藏
页码:232 / 235
页数:4
相关论文
共 50 条
  • [1] Developing pharmacological therapies for Alzheimer disease
    Iqbal, K.
    Grundke-Iqbal, I.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (17) : 2234 - 2244
  • [2] Developing pharmacological therapies for Alzheimer disease
    K. Iqbal
    I. Grundke-Iqbal
    Cellular and Molecular Life Sciences, 2007, 64 : 2234 - 2244
  • [3] Opportunities and challenges in developing Alzheimer disease therapeutics
    Khalid Iqbal
    Inge Grundke-Iqbal
    Acta Neuropathologica, 2011, 122 : 543 - 549
  • [4] Opportunities and challenges in developing Alzheimer disease therapeutics
    Iqbal, Khalid
    Grundke-Iqbal, Inge
    ACTA NEUROPATHOLOGICA, 2011, 122 (05) : 543 - 549
  • [5] Myelin changes in Alexander disease
    Gomez-Pinedo, U.
    Duran-Moreno, M.
    Sirerol-Piquer, S.
    Matias-Guiu, J.
    NEUROLOGIA, 2018, 33 (08): : 526 - 533
  • [6] Alexander disease
    Gordon, N
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2003, 7 (06) : 395 - 399
  • [7] Alexander Disease
    Messing, Albee
    Brenner, Michael
    Feany, Mel B.
    Nedergaard, Maiken
    Goldman, James E.
    JOURNAL OF NEUROSCIENCE, 2012, 32 (15) : 5017 - 5023
  • [8] Alexander Disease
    Hartog, Laura
    Dekeyzer, Sven
    Vanden Bossche, Stephanie
    JOURNAL OF THE BELGIAN SOCIETY OF RADIOLOGY, 2021, 105 (01):
  • [9] ALEXANDER DISEASE
    ELIAN, JC
    FRAPPAZ, D
    REYNAUD, J
    PERROT, S
    FREYCON, F
    PEDIATRIE, 1991, 46 (04): : 373 - 377
  • [10] Content of brain aluminum is not elevated in Alzheimer disease
    Bjertness, E
    Candy, JM
    Torvik, A
    Ince, P
    McArthur, F
    Taylor, GA
    Johansen, SW
    Alexander, J
    Gronnesby, JK
    Bakketeig, LS
    Edwardson, JA
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1996, 10 (03) : 171 - 174